Whalegun
Home

Biomarin Pharmaceutical BMRN paid Venn Strategies $30K for lobbying in Q2 2017 · Health Issues, Taxation

Trade details

Type
Lobbying report
Amount
$30,000
Quarter
Q2 2017
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
26/07/06

$30K on lobbying in 2017

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 17/05/31~17/07/30

Biomarin Pharmaceutical's other lobbying reports